Towards more accurate, reproducible, and robust measurement and analysis of biological samples: International Standardization Efforts within ISO/TC 276 – Biotechnology
NEW: please register yourself, and you will receive your link to the webinar: https://attendee.gotowebinar.com/rt/3473335634278123778
INVITED SPEAKER: Sheng Lin-Gibson Dr., Division Chief of NIST (USA)
Dr. Sheng Lin-Gibson is the Chief of NIST (USA National Institute of Standards and Technology) Biosystems and Biomaterials Division and has directed its Regenerative Medicine Programs since 2015. She serves as the Chairperson of the U.S. Mirror Committee to ISO/TC 276: Biotechnology as well as the Convenor of ISO/TC 276 Working Group 3: Analytical Methods and is leading or contributing to the development of several international standards for emerging biotechnology, including genomic and cell measurements. Dr. Lin-Gibson is the NIST lead for various joint NIST/SCB efforts to coordinate the development of standards for regenerative medicine. She co-chairs the Multi-Agency Tissue Engineering Science (MATES) Working Group, an ad hoc interagency group that ensures communication and coordination among US Federal Agencies. She is a NIST participant on the Technical Advisory Committee (TAC) of NIIMBL, a U.S. Manufacturing Institute aimed to accelerate biopharmaceutical manufacturing. Her current research portfolio includes the measurement of cells, microbial systems, and biomaterials to provide data that underpin the development of science-based standards. She has published more than 80 scientific papers and book chapters. She has served on numerous NSF, NIH, and NIST expert review panels, and is a recipient of three Department of Commerce Bronze Medals.